Extract
ChemoCentryx Raises $33 Million in Private Financing.
SAN CARLOS, Calif. -- ChemoCentryx, Inc. today announced that it has closed a private financing round raising gross proceeds of $33 million. HBM BioVentures and Alta Partners acted as significant new investors in the round. Additional participants included new investors GIMV and Hanseatic, as well as returning investors Techne Corporation, OrbiMed Advisors, He...
See the full content of this document
Sponsored links
